| PI3K/HDAC Inhibitor |
CUDC-907 |
1339928-25-4 |
| N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide |
BMS-3 |
1338247-30-5 |
| azd4635 |
AZD4635 |
1321514-06-0 |
| ACY-1215 |
ACY1215 |
1316214-52-4 |
| GDC-0032 |
GDC 0032 |
1282512-48-4 |
| LY 2874455 |
LY2874455 |
1254473-64-7 |
| LGK-974 |
2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺 |
1243244-14-5 |
| mi503 |
MI-503 |
1857417-13-0 |
| LRRK2-IN-1 |
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-84-2 |
| ACK1-B19 |
5,11-二氢-2-((2-甲氧基-4-(4-甲基-1-哌嗪基)苯基)氨基)-11-甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-46-6 |
| 2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |
2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-50-2 |
| 3-Amino-6-[4-(methylsulfonyl)phenyl]-N-phenyl-2-pyrazinecarboxamide |
3-氨基-6-[4-(甲基磺酰基)苯基]-N-苯基-2-吡嗪甲酰胺 |
1232410-49-9 |
| VE 822 |
VE-822 |
1232416-25-9 |
| Abemaciclib mesylate (LY2835219) |
LY2835219 |
1231930-82-7 |
| H3B-6527 |
H3B-6527 |
1702259-66-2 |
| SteMRegenin 1 |
SR-1;SR1 |
1227633-49-9 |
| GSK591 |
GSK591 (EPZ-015866) |
1616391-87-7 |
| AZD8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
| HA-15 |
HA-15 |
1609402-14-3 |
| DLin-M-C3-DMA |
4-(N,N-二甲基氨基)丁酸(二亚油基)甲酯 |
1224606-06-7 |
